Addus HomeCare Co. (NASDAQ:ADUS) Shares Acquired by TimesSquare Capital Management LLC

TimesSquare Capital Management LLC boosted its position in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 28.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 355,750 shares of the company's stock after purchasing an additional 78,835 shares during the quarter. TimesSquare Capital Management LLC owned about 1.96% of Addus HomeCare worth $44,593,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. New York State Common Retirement Fund increased its holdings in Addus HomeCare by 6.0% during the 4th quarter. New York State Common Retirement Fund now owns 14,098 shares of the company's stock worth $1,767,000 after purchasing an additional 800 shares during the period. State of New Jersey Common Pension Fund D increased its holdings in Addus HomeCare by 17.1% during the 4th quarter. State of New Jersey Common Pension Fund D now owns 17,464 shares of the company's stock worth $2,189,000 after purchasing an additional 2,553 shares during the period. Vista Finance LLC purchased a new position in Addus HomeCare during the 4th quarter worth $351,000. Vontobel Holding Ltd. increased its holdings in Addus HomeCare by 22.9% during the 4th quarter. Vontobel Holding Ltd. now owns 3,132 shares of the company's stock worth $393,000 after purchasing an additional 583 shares during the period. Finally, Equitable Trust Co. increased its holdings in Addus HomeCare by 47.1% during the 4th quarter. Equitable Trust Co. now owns 7,096 shares of the company's stock worth $889,000 after purchasing an additional 2,271 shares during the period. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the sale, the chief executive officer now owns 79,397 shares of the company's stock, valued at approximately $9,905,569.72. The trade was a 23.95 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the sale, the executive vice president now directly owns 10,217 shares of the company's stock, valued at approximately $1,236,257. This represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 39,750 shares of company stock worth $4,930,750 in the last ninety days. 4.60% of the stock is owned by insiders.

Addus HomeCare Stock Performance

ADUS stock traded down $2.84 on Friday, hitting $109.23. 242,244 shares of the company's stock were exchanged, compared to its average volume of 164,640. Addus HomeCare Co. has a 12-month low of $85.94 and a 12-month high of $136.72. The firm has a 50 day moving average price of $125.04 and a two-hundred day moving average price of $126.75. The stock has a market cap of $1.98 billion, a P/E ratio of 25.00, a price-to-earnings-growth ratio of 1.46 and a beta of 1.00.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the company. Stephens raised their price objective on Addus HomeCare from $143.00 to $145.00 and gave the stock an "overweight" rating in a report on Wednesday, November 6th. Royal Bank of Canada reiterated an "outperform" rating and issued a $136.00 price target on shares of Addus HomeCare in a report on Thursday, November 14th. Macquarie reiterated an "outperform" rating and issued a $139.00 price target on shares of Addus HomeCare in a report on Monday, November 4th. Oppenheimer lifted their price target on Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, January 24th. Finally, Citizens Jmp upgraded Addus HomeCare to a "strong-buy" rating in a report on Monday, December 16th. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average target price of $134.22.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.